Weiwei Zhu, MS

Zhu_Weiwei__205x293.jpg

“I have a longstanding interest in using biostatistics to advance medical research. Working at KPWHRI gives me a great opportunity to contribute to challenging projects with rich, relevant data and make a national impact on health care systems.”

Weiwei Zhu, MS

Biostatistician III, Kaiser Permanente Washington Health Research Institute

Weiwei.Zhu@kp.org
206-442-5215

Biography

Weiwei Zhu, MS, joined Kaiser Permanente Washington Health Research Institute's Biostatistics Unit in 2009. She works closely with Senior Investigator Diana Miglioretti, PhD, to design studies, manage data, and conduct statistical analyses for the Breast Cancer Surveillance Consortium (BCSC)—the National Cancer Institute’s seven-site network of mammography researchers. She has been a key member of the BCSC Statistical Coordinating Center for almost 10 years. Her work studying the breast screening benefits and risks played an essential role in an American Cancer Society screening guideline change in 2015.

Ms. Zhu also works with Senior Investigator Denise Boudreau, PhD, to quantify the serious risks of misuse, abuse, and addiction associated with long-term opioid use.  This multi-site study will use electronic health record data and survey interviews to provide estimates of long-term opioid use risks in two cohorts.

After beginning her medical research career as an intern at the University of Texas MD Anderson Cancer Center in 2007, Ms. Zhu served as a biostatistician at the Moffitt Cancer Center and Research Institute in Florida.

Research interests and experience

 

Recent publications

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K. Family history and breast cancer risk among older women in the Breast Cancer Surveillance Consortium cohort. JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642. PubMed

Miles R, Wan F, Onega TL, Lenderink-Carpenter A, O'Meara ES, Zhu W, Henderson LM, Haas JS, Hill DA, Tosteson ANA, Wernli KJ, Alford-Teaster J, Lee JM, Lehman CD, Lee CI. Underutilization of supplemental magnetic resonance imaging screening among patients at high breast cancer risk. J Womens Health (Larchmt). 2018 Jan 17. doi: 10.1089/jwh.2017.6623. [Epub ahead of print]. PubMed

Henderson LM, Hubbard RA, Zhu W, Weiss J, Wernli KJ, Goodrich ME, Kerlikowske K, DeMartini W, Ozanne EM, Onega T. Preoperative breast magnetic resonance imaging use by breast density and family history of breast cancer. J Womens Health (Larchmt). 2018 Jan 15. doi: 10.1089/jwh.2017.6428. [Epub ahead of print]. PubMed

Onega T, Weiss JE, Goodrich ME, Zhu W, DeMartini WB, Kerlikowske K, Ozanne E, Tosteson ANA, Henderson LM, Buist DSM, Wernli KJ, Herschorn SD, Hotaling E, O'Donoghue C, Hubbard R. Relationship between preoperative breast MRI and surgical treatment of non-metastatic breast cancer. J Surg Oncol. 2017 Dec;116(8):1008-1015. doi: 10.1002/jso.24796. Epub 2017 Nov 11. PubMed

Henderson LM, Hubbard RA, Sprague BL, Zhu W, Kerlikowske K. Increased risk of developing breast cancer after a false-positive screening mammogram. Cancer Epidemiol Biomarkers Prev. 2015;24(12):1882-9. doi: 10.1158/1055-9965.EPI-15-0623. PubMed

 

Research

Insomnia-phone-therapy-elderly-blog_1col.jpg

Phone therapy for insomnia shown to improve sleep

A study among Kaiser Permanente members with sleep problems and osteoarthritis shows promise for overcoming obstacles to treatment.

News

3-D_Mammography_1col.jpg

Race, income, education affect access to 3D mammography

The technology’s potential benefits to detect breast cancer earlier are not equally shared among all women, researchers find.